New drug CPV-104 enters first human trials for rare kidney disorder
NCT ID NCT07483827
First seen Mar 28, 2026 · Last updated May 21, 2026 · Updated 5 times
Summary
This study tests a new medicine called CPV-104 for the first time in people. It is designed to calm an overactive part of the immune system that causes damage in C3 glomerulopathy (C3G), a rare kidney disease. The trial includes healthy adults and people with C3G to check safety, how the body handles the drug, and any side effects. The main goal is safety, not yet whether the drug works.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEALTHY ADULT PARTICIPANTS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Amsterdam UMC Stichting
RECRUITINGAmsterdam, Netherlands
-
Centre Hospitalier Universitaire De Toulouse
RECRUITINGToulouse, France
-
Clinica Universidad De Navarra
RECRUITINGPamplona, Spain
-
Cliniques universitaires Saint-Luc
RECRUITINGBrussels, Belgium
-
Fakultni Thomayerova nemocnice
RECRUITINGPrague, Czechia
-
Fundacio Puigvert
NOT_YET_RECRUITINGBarcelona, Spain
-
Hospital Curry Cabral - Centro Hospitalar de Lisboa Central - ULS Sao José
RECRUITINGLisbon, Portugal
-
Hospital Universitario 12 De Octubre
RECRUITINGMadrid, Spain
-
Hospital Universitario Virgen De La Macarena
RECRUITINGSeville, Spain
-
Hôpital Européen Georges-Pompidou HEGP
NOT_YET_RECRUITINGParis, France
-
Karolinska University Hospital
RECRUITINGHuddinge, Sweden
-
Laiko General Hospital Of Athens
RECRUITINGAthens, Greece
-
Medizinische Universität Wien
RECRUITINGVienna, Austria
-
Pauls Stradins Clinical University Hospital
RECRUITINGRiga, Latvia
-
University Hospital Virgen Del Rocio S.L.
RECRUITINGSeville, Spain
-
Vilnius University Hospital Santaros Klinikos
RECRUITINGVilnius, Lithuania
Conditions
Explore the condition pages connected to this study.